A study on opportunistic enteric parasites in 80 HIV seropositive patients
Talib, S.H.; Singh, J.
Indian Journal of Pathology and Microbiology 41(1): 31-37
1998
ISSN/ISBN: 0377-4929 PMID: 9581074 Document Number: 527304
AIDS is characteristically associated with several opportunistic enteric protozoal infestations that cause chronic and at times fatal diarrhoeas. A study is undertaken to isolated opportunistic enteric parasites in 80 HIV seropositive patients. An attempt is made to correlate and signify the presence of coexistent oral candidosis and enteric pathogens.
Document emailed within 1 workday
Related Documents
Pinlaor, S.; Mootsikapun, P.; Pinlaor, P.; Pipitgool, V.; Tuangnadee, R. 2005: Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects Southeast Asian Journal of Tropical Medicine and Public Health 36(4): 841-845Chakraborty, N.; Mukherjee, A.; Santra, S.; Sarkar, R.Nath.; Banerjee, D.; Guha, S.Kamal.; Chakraborty, S.; Bhattacharyya, S.Kumar. 2008: Current trends of opportunistic infections among HIV-seropositive patients from Eastern India Japanese Journal of Infectious Diseases 61(1): 49-53
Andualem, B.; Kassu, A.; Moges, F.; Gedefaw, M.; Diro, E.; Mengistu, G.; Andargie, G. 2007: Diarrhoea-associated parasites in HIV-1 seropositive and sero-negative patients in a teaching hospital, Northwest Ethiopia Ethiopian Medical Journal 45(2): 165-170
Alemu, A.; Shiferaw, Y.; Getnet, G.; Yalew, A.; Addis, Z. 2011: Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, North West Ethiopia Asian Pacific Journal of Tropical Medicine 4(8): 661-665
Uraz, G.; Günalp, A. 1979: The effect of parasites on enteric bacterial flora Mikrobiyoloji Bulteni 13(1): 143-152
Dhungel,B.A.; Dhungel,K.U.; Easow,J.M.; Singh,Y.I. 2008: Opportunistic infection among HIV seropositive cases in Manipal Teaching Hospital, Pokhara, Nepal Kathmandu University Medical Journal (kumj): 3, 335-339
Sharma, S.; Dhungana, G.P.; Pokharel, B.M.; Rijal, B.P. 2009: Clinical features of HIV/AIDS and various opportunistic infections in relation to antiretroviral status among HIV seropositive individuals from Central Nepal Kathmandu University Medical Journal 7(28): 355-359
Prasetyo, R.H. 2016: Survey of House Rat Intestinal Parasites from Surabaya District, East Java, Indonesia that can Cause Opportunistic Infections in Humans Southeast Asian Journal of Tropical Medicine and Public Health 47(2): 194-198
Pierelli, F.; Soldati, G.; Zambardi, P.; Garrubba, C.; Spadaro, M.; Tilia, G.; Pauri, F.; Morocutti, C. 1993: Electrophysiological study (VEP, BAEP) in HIV-1 seropositive patients with and without AIDS Acta Neurologica Belgica 93(2): 78-87
Haider, S.; Grabovac, I.; Berner, C.; Lamprecht, T.; Fenzl, K-Heinrich.; Erlacher, L.; Quittan, M.; Dorner, T.E. 2019: Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study Clinical and Experimental Rheumatology 37(4): 585-592
Khanal, V.K.; Jha, N.; Karki, P.; Paudel, I.S. 2014: Opportunistic infections and clinical profile of HIV/AIDS patients: a study from eastern region of Nepal Nepal Medical College Journal: Nmcj 16(2-4): 194-197
Okome-Nkoumou, M.; Guiyedi, V.; Ondounda, M.; Efire, N.; Clevenbergh, P.; Dibo, M.; Dzeing-Ella, A. 2014: Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study American Journal of Tropical Medicine and Hygiene 90(2): 211-215
Disdier, O.M.; Pérez, C.M.; Suárez, E. 1999: A comparative study of indinavir versus ritonavir for assessing the development of opportunistic diseases in adult AIDS patients Boletin de la Asociacion Medica de Puerto Rico 91(7-12): 85-90
Wumba, R.; Enache-Angoulvant, A.; Develoux, M.; Mulumba, A.; Mulumba, P.M.; Hennequin, C.; Odio, T.W.; Biligui, S.; Sala, J.; Thellier, M. 2007: Prevalence of opportunistic digestive parasitic infections in Kinshasa, Democratic Republic of Congo. Results of a preliminary study in 50 AIDS patients Medecine Tropicale: Revue du Corps de Sante Colonial 67(2): 145-148
Rana, A.; Gogna, A.; Kabi, B.C. 2020: A study to correlate the serum levels of interleukin 6 with the disease activity indices (CDAi and DAS28 ESR) in seropositive rheumatoid arthritis patients Journal of the Association of Physicians of India 68(1): 69
Farid, Z.; Trabolsi, B.; Yassin, W.; Watten, R.H.; Abdel Wahab, M.F. 1979: Enteric fevers in Egypt with emphasis on the chronic enteric carrier condition Journal of the Egyptian Public Health Association 54(1-2): 9-14
Thayer, W.R.; Kirsner, J.B. 1980: Enteric and extra-enteric complications of intestinal bypass and inflammatory bowel disease. Are there some clues? Gastroenterology 78(5 Part 1): 1097-1100
Ohyama, M.; Matsumura, M.; Katsuta, K.; Nobori, T.; Matsuyama, H.; Fukami, K.; Kiyota, R.; Yano, H.; Shima, T.; Ogawa, K. 1990: A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(6): 1211-1216
Podzamczer, D.; Barros, C.; Berenguer, J.; Gutiérrez, Félix.; Iribarren, Jé.Antonio.; Miró, Jé.M.; Molina, Jé.Pérez.; Podzamczer, D.; Aguirrebengoa, K.; Arribas, Jé.Ramón.; Boix, V.; Cahn, P.; Castro, A.; Caylá, J.; Cobo, J.; Corzo, J.Enrique.; de la Torre, J.; Dronda, F.; Ena, J.; Falcó, Vç.; Ferrer, E.; Labarga, P.; Locutura, J.; Mallolas, J.; Moreno, S.; Ocampo, A.; Ocaña, Ján.; Padilla, Bén.; Elías, Jús.Pérez.; Polo, R.; Portilla, Jín.; Riera, M.; Rivero, A.; Salavert, M.; Sanz, Jé. 2008: Treatment of opportunistic infections in adolescent and adult patients infected with the human immunodeficiency virus during the era of highly active antiretroviral therapy. AIDS Study Group (GESIDA) and National AIDS Plan Expert Committee Enfermedades Infecciosas y Microbiologia Clinica 26(6): 356-379
Semmanaselvan, K.; Mukaddam, Q.I.; Naik, M. 2015: An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease Journal of the Association of Physicians of India 63(7): 27-32